CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Operating Profit

Annual Operating Profit:

$195.12M+$108.31M(+124.77%)
December 31, 2024

Summary

  • As of today, CPRX annual operating income is $195.12 million, with the most recent change of +$108.31 million (+124.77%) on December 31, 2024.
  • During the last 3 years, CPRX annual operating profit has risen by +$142.74 million (+272.48%).
  • CPRX annual operating profit is now at all-time high.

Performance

CPRX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Quarterly Operating Profit:

$66.30M+$2.93M(+4.63%)
June 30, 2025

Summary

  • As of today, CPRX quarterly operating income is $66.30 million, with the most recent change of +$2.93 million (+4.63%) on June 30, 2025.
  • Over the past year, CPRX quarterly operating profit has increased by +$12.05 million (+22.22%).
  • CPRX quarterly operating profit is now at all-time high.

Performance

CPRX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

TTM Operating Profit:

$243.42M+$12.05M(+5.21%)
June 30, 2025

Summary

  • As of today, CPRX TTM operating income is $243.42 million, with the most recent change of +$12.05 million (+5.21%) on June 30, 2025.
  • Over the past year, CPRX TTM operating profit has increased by +$157.54 million (+183.45%).
  • CPRX TTM operating profit is now at all-time high.

Performance

CPRX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

CPRX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+124.8%+22.2%+183.4%
3Y3 Years+272.5%+132.1%+234.9%
5Y5 Years+513.1%+544.8%+498.2%

CPRX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+272.5%at high+278.3%at high+220.6%
5Y5-Yearat high+513.1%at high+278.3%at high+502.4%
All-TimeAll-Timeat high+652.8%at high+278.3%at high+789.7%

CPRX Operating Profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$66.30M(+4.6%)
$243.42M(+5.2%)
Mar 2025
-
$63.37M(+0.8%)
$231.37M(+18.6%)
Dec 2024
$195.12M(+124.8%)
$62.84M(+23.4%)
$195.12M(+12.2%)
Sep 2024
-
$50.91M(-6.2%)
$173.97M(+102.6%)
Jun 2024
-
$54.25M(+100.0%)
$85.88M(+9.6%)
Mar 2024
-
$27.13M(-34.9%)
$78.33M(-9.8%)
Dec 2023
$86.81M(-14.8%)
$41.69M(+212.1%)
$86.81M(+14.3%)
Sep 2023
-
-$37.19M(-179.6%)
$75.92M(-45.1%)
Jun 2023
-
$46.70M(+31.1%)
$138.21M(+15.1%)
Mar 2023
-
$35.61M(+15.6%)
$120.08M(+17.9%)
Dec 2022
$101.84M(+94.4%)
$30.80M(+22.7%)
$101.84M(+21.6%)
Sep 2022
-
$25.10M(-12.1%)
$83.78M(+15.3%)
Jun 2022
-
$28.57M(+64.5%)
$72.68M(+21.2%)
Mar 2022
-
$17.37M(+36.3%)
$59.95M(+14.4%)
Dec 2021
$52.38M(+26.8%)
$12.74M(-9.0%)
$52.38M(+8.5%)
Sep 2021
-
$14.00M(-11.6%)
$48.26M(+5.0%)
Jun 2021
-
$15.84M(+61.6%)
$45.96M(+13.8%)
Mar 2021
-
$9.80M(+13.7%)
$40.40M(-2.2%)
Dec 2020
$41.30M(+29.8%)
$8.62M(-26.4%)
$41.30M(+1.5%)
Sep 2020
-
$11.70M(+13.8%)
$40.69M(-5.0%)
Jun 2020
-
$10.28M(-3.9%)
$42.83M(-1.6%)
Mar 2020
-
$10.70M(+33.6%)
$43.51M(+36.7%)
Dec 2019
$31.82M(+190.2%)
$8.01M(-42.2%)
$31.82M(+254.6%)
Sep 2019
-
$13.85M(+26.3%)
$8.97M(+168.7%)
Jun 2019
-
$10.96M(+1209.5%)
-$13.05M(+57.0%)
Mar 2019
-
-$987.80K(+93.3%)
-$30.35M(+14.0%)
Dec 2018
-$35.30M(-89.0%)
-$14.84M(-81.4%)
-$35.30M(-35.9%)
Sep 2018
-
-$8.18M(-29.1%)
-$25.96M(-17.5%)
Jun 2018
-
-$6.34M(-6.8%)
-$22.09M(-10.8%)
Mar 2018
-
-$5.93M(-7.6%)
-$19.93M(-6.7%)
Dec 2017
-$18.68M(+0.0%)
-$5.51M(-28.0%)
-$18.68M(-6.9%)
Sep 2017
-
-$4.31M(-3.0%)
-$17.48M(-2.3%)
Jun 2017
-
-$4.18M(+10.7%)
-$17.09M(+3.6%)
Mar 2017
-
-$4.68M(-8.5%)
-$17.72M(+8.1%)
Dec 2016
-$18.68M(+8.4%)
-$4.31M(-10.2%)
-$19.28M(+8.9%)
Sep 2016
-
-$3.91M(+18.7%)
-$21.16M(+5.0%)
Jun 2016
-
-$4.81M(+22.8%)
-$22.26M(+0.4%)
Mar 2016
-
-$6.24M(-0.7%)
-$22.34M(-9.5%)
Dec 2015
-$20.40M
-$6.19M(-23.4%)
-$20.40M(-12.1%)
Sep 2015
-
-$5.02M(-2.5%)
-$18.19M(-5.3%)
DateAnnualQuarterlyTTM
Jun 2015
-
-$4.90M(-14.1%)
-$17.28M(-12.4%)
Mar 2015
-
-$4.29M(-7.7%)
-$15.38M(-5.4%)
Dec 2014
-$14.59M(-41.5%)
-$3.98M(+3.0%)
-$14.59M(-9.6%)
Sep 2014
-
-$4.11M(-37.4%)
-$13.31M(-6.9%)
Jun 2014
-
-$2.99M(+14.8%)
-$12.45M(-2.8%)
Mar 2014
-
-$3.51M(-29.6%)
-$12.11M(-17.5%)
Dec 2013
-$10.31M(-97.5%)
-$2.71M(+16.6%)
-$10.31M(-13.2%)
Sep 2013
-
-$3.25M(-22.3%)
-$9.11M(-27.4%)
Jun 2013
-
-$2.65M(-55.6%)
-$7.15M(-28.5%)
Mar 2013
-
-$1.71M(-13.3%)
-$5.56M(-6.5%)
Dec 2012
-$5.22M(+14.2%)
-$1.51M(-17.3%)
-$5.22M(+9.2%)
Sep 2012
-
-$1.28M(-20.3%)
-$5.75M(-2.7%)
Jun 2012
-
-$1.07M(+21.8%)
-$5.60M(+5.6%)
Mar 2012
-
-$1.36M(+32.9%)
-$5.93M(+2.5%)
Dec 2011
-$6.08M(-34.8%)
-$2.03M(-79.9%)
-$6.08M(-15.4%)
Sep 2011
-
-$1.13M(+19.1%)
-$5.27M(-4.4%)
Jun 2011
-
-$1.40M(+8.0%)
-$5.05M(-1.3%)
Mar 2011
-
-$1.52M(-24.4%)
-$4.98M(-10.4%)
Dec 2010
-$4.51M(+38.0%)
-$1.22M(-34.4%)
-$4.51M(-1.2%)
Sep 2010
-
-$908.50K(+31.9%)
-$4.46M(+7.9%)
Jun 2010
-
-$1.33M(-26.9%)
-$4.85M(+8.3%)
Mar 2010
-
-$1.05M(+10.2%)
-$5.28M(+27.4%)
Dec 2009
-$7.28M(+33.2%)
-$1.17M(+9.5%)
-$7.28M(+26.5%)
Sep 2009
-
-$1.29M(+26.9%)
-$9.90M(+14.1%)
Jun 2009
-
-$1.77M(+41.9%)
-$11.52M(+5.7%)
Mar 2009
-
-$3.04M(+19.7%)
-$12.21M(-12.1%)
Dec 2008
-$10.89M(-116.7%)
-$3.79M(-30.1%)
-$10.89M(-32.1%)
Sep 2008
-
-$2.91M(-18.3%)
-$8.25M(-31.3%)
Jun 2008
-
-$2.46M(-42.9%)
-$6.28M(-19.5%)
Mar 2008
-
-$1.72M(-50.9%)
-$5.25M(-4.5%)
Dec 2007
-$5.03M(-73.2%)
-$1.14M(-20.2%)
-$5.03M(-5.4%)
Sep 2007
-
-$950.40K(+33.9%)
-$4.77M(+7.6%)
Jun 2007
-
-$1.44M(+4.0%)
-$5.16M(-26.5%)
Mar 2007
-
-$1.50M(-69.1%)
-$4.08M(-57.9%)
Dec 2006
-$2.90M(-59.3%)
-$885.20K(+34.0%)
-$2.58M(-52.1%)
Sep 2006
-
-$1.34M(-276.0%)
-$1.70M(-376.0%)
Jun 2006
-
-$357.00K
-$357.00K
Dec 2005
-$1.82M(-235.6%)
-
-
Dec 2004
-$543.00K(-25.0%)
-
-
Dec 2003
-$434.30K(-69.7%)
-
-
Dec 2002
-$255.90K
-
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual operating income?
  • What is the all-time high annual operating profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual operating profit year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. TTM operating profit year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual operating income?

The current annual operating profit of CPRX is $195.12M

What is the all-time high annual operating profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual operating income is $195.12M

What is Catalyst Pharmaceuticals, Inc. annual operating profit year-on-year change?

Over the past year, CPRX annual operating income has changed by +$108.31M (+124.77%)

What is Catalyst Pharmaceuticals, Inc. quarterly operating income?

The current quarterly operating profit of CPRX is $66.30M

What is the all-time high quarterly operating profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly operating income is $66.30M

What is Catalyst Pharmaceuticals, Inc. quarterly operating profit year-on-year change?

Over the past year, CPRX quarterly operating income has changed by +$12.05M (+22.22%)

What is Catalyst Pharmaceuticals, Inc. TTM operating income?

The current TTM operating profit of CPRX is $243.42M

What is the all-time high TTM operating profit for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high TTM operating income is $243.42M

What is Catalyst Pharmaceuticals, Inc. TTM operating profit year-on-year change?

Over the past year, CPRX TTM operating income has changed by +$157.54M (+183.45%)
On this page